The Globe and Mail reports in its Thursday, Feb. 5, edition that National Bank Financial analyst Jaeme Gloyn is keeping his "outperform" recommendation for Trisura Group intact. The Globe's David Leeder writes in the Eye On Equities column that Mr. Gloyn tweaked his share target ahead by $2 to $59. Analysts on average target the shares at $54.50. The Globe says Trisura Group is one of Mr. Gloyn's "top ideas." Mr. Gloyn says in a note: "We expect Trisura Group will continue to deliver double-digit top-line growth, mid-80-per-cent combined ratio, and mid-to-high teens ROE supported by ongoing strong specialty insurance operations, a scaling U.S. primary insurance platform, higher quality U.S. programs business and a rock-solid balance sheet. In our view, Trisura Group has delivered solid results and demonstrated value in the U.S. programs franchise while the market continues to price in an overly pessimistic level of risk around the legacy overhang. A move back toward its historical average P/E implies over 40-per-cent upside before factoring in any earnings growth." The Globe reported on May 7 and Oct. 31 that Mr. Gloyn had reaffirmed his "outperform" recommendation for Trisura. It was then worth $45.30 and $41.89.